<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="18344">Kynurenic acid</z:chebi>, the only known endogenous <z:chebi fb="68" ids="48706">antagonist</z:chebi> of the excitatory amino acid receptors, exerts neuroprotective effect in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="18344">Kynurenic acid</z:chebi> poorly while its bioprecursor, l-<z:chebi fb="0" ids="28683">kynurenine</z:chebi> (L-KYN) completely crosses the blood-brain barrier </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of our study was to investigate the effect of intravenous l-KYN (0.3, 1, and 3 mg/kg) on the <z:mpath ids='MPATH_458'>normal</z:mpath> and the unilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> induced ischemic corticocerebral blood flow (cCBF) measured by hydrogen polarography in conscious rabbits </plain></SENT>
<SENT sid="3" pm="."><plain>Administration of l-KYN produced a significant increase in the <z:mpath ids='MPATH_458'>normal</z:mpath> cCBF; the peak values were recorded at the dose of 1 mg/kg (187% at 120 and 150 mins </plain></SENT>
<SENT sid="4" pm="."><plain>respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>The cCBF-improving effect of l-KYN was immediate and highly pronounced also in rabbits with carotid occlusion (peak value was 192% at 120 mins. at the dose of 1 mg/kg) </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with either <z:chebi fb="28" ids="16684">atropine</z:chebi> or Nomega-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi>-<z:chebi fb="36" ids="29309">methyl</z:chebi>-<z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>) prevented the l-KYN induced enhancement of the <z:mpath ids='MPATH_458'>normal</z:mpath> and the ischemic cCBF alike </plain></SENT>
<SENT sid="7" pm="."><plain>It is suggested that the cCBF-increasing effect of l-KYN might be mediated by activation of cholinergic and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> pathways </plain></SENT>
</text></document>